PH12019501971A1 - Intradialytic use of sodium thiosulfate - Google Patents
Intradialytic use of sodium thiosulfateInfo
- Publication number
- PH12019501971A1 PH12019501971A1 PH12019501971A PH12019501971A PH12019501971A1 PH 12019501971 A1 PH12019501971 A1 PH 12019501971A1 PH 12019501971 A PH12019501971 A PH 12019501971A PH 12019501971 A PH12019501971 A PH 12019501971A PH 12019501971 A1 PH12019501971 A1 PH 12019501971A1
- Authority
- PH
- Philippines
- Prior art keywords
- sodium thiosulfate
- intradialytic
- methods
- thiosulfate
- subject undergoing
- Prior art date
Links
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 title abstract 2
- 235000019345 sodium thiosulphate Nutrition 0.000 title abstract 2
- 238000001631 haemodialysis Methods 0.000 abstract 2
- 230000000322 hemodialysis Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468871P | 2017-03-08 | 2017-03-08 | |
| PCT/US2018/021069 WO2018165108A1 (en) | 2017-03-08 | 2018-03-06 | Intradialytic use of sodium thiosulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12019501971A1 true PH12019501971A1 (en) | 2020-06-15 |
Family
ID=63446695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12019501971A PH12019501971A1 (en) | 2017-03-08 | 2019-08-28 | Intradialytic use of sodium thiosulfate |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US10744156B2 (enExample) |
| EP (2) | EP3592824B1 (enExample) |
| JP (3) | JP7416622B2 (enExample) |
| KR (4) | KR102758644B1 (enExample) |
| AR (1) | AR111236A1 (enExample) |
| AU (2) | AU2018231072B2 (enExample) |
| BR (1) | BR112019018646A2 (enExample) |
| CA (1) | CA3055107A1 (enExample) |
| ES (1) | ES2992792T3 (enExample) |
| IL (4) | IL302827B2 (enExample) |
| NZ (1) | NZ756704A (enExample) |
| PH (1) | PH12019501971A1 (enExample) |
| TW (3) | TWI789378B (enExample) |
| WO (1) | WO2018165108A1 (enExample) |
| ZA (2) | ZA202105781B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2992792T3 (en) | 2017-03-08 | 2024-12-18 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| MD3817751T2 (ro) | 2018-07-03 | 2025-10-31 | Fennec Pharmaceuticals Inc | Compoziții de tiosulfat de sodiu anhidru |
| US11850313B2 (en) * | 2019-12-20 | 2023-12-26 | The London Health Sciences Centre Research Inc. | Method and compositions for protecting tissue |
| WO2024092228A2 (en) * | 2022-10-28 | 2024-05-02 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Localized delivery of sodium thiosulfate nanoparticles to mitigate arterial calcification |
| CN116573782B (zh) * | 2023-04-03 | 2023-11-03 | 迁安市宏奥工贸有限公司 | 脱硫废液的处理方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341151C (en) | 1985-09-10 | 2000-12-05 | Elias Klein | Osmotic agents form peritoneal dialysis |
| US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
| US6380163B1 (en) | 1992-12-22 | 2002-04-30 | Baxter International Inc. | Peritoneal dialysis solutions with polypeptides |
| FI98538C (fi) * | 1993-10-20 | 1997-07-10 | Enso Gutzeit Oy | Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä |
| US6306836B1 (en) | 1994-01-21 | 2001-10-23 | Baxter International Inc. | Peritoneal dialysis solutions containing maltodextrins and amino acids |
| US6436969B1 (en) | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
| CA2422850C (en) * | 1999-09-22 | 2009-03-03 | Advanced Renal Technologies | High citrate dialysate and uses thereof |
| CA2406081C (en) * | 2000-04-26 | 2009-12-22 | Oregon Health Sciences University | Administration of a thiol-based chemoprotectant compound |
| JP4882054B2 (ja) | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| CA2537222A1 (en) | 2003-07-09 | 2005-01-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
| WO2006001345A1 (ja) | 2004-06-23 | 2006-01-05 | Kyowa Hakko Kogyo Co., Ltd. | Ｌ－リジン・クエン酸塩結晶 |
| US20070154570A1 (en) | 2004-09-29 | 2007-07-05 | Miller Christopher C | Use of nitric oxide in the treatment and disinfection of biofilms |
| US7834065B2 (en) | 2005-01-31 | 2010-11-16 | Bmg Incorporated | Medical-use two part reactive adhesive and medical-use resin having self-degradation property |
| US20090304600A1 (en) * | 2008-06-09 | 2009-12-10 | Anupkumar Shetty | Intradialytic administration of sodium thiosulfate |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| DK2451435T4 (da) | 2009-07-08 | 2022-02-28 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Natriumthiosulfat-indeholdende farmaceutiske sammensætninger |
| WO2013023217A1 (en) | 2011-08-11 | 2013-02-14 | Board Of Regents, The University Of Texas System | Method of measuring and monitoring in vivo nitrite levels |
| AU2013212264B2 (en) | 2012-01-23 | 2017-05-18 | Santalis Pharmaceuticals Inc. | Sandalwood oil and its uses related to clostridium infections |
| JP2015516407A (ja) * | 2012-05-10 | 2015-06-11 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 異所性石灰化の治療のためのチオ硫酸ナトリウム |
| JP5486069B1 (ja) * | 2012-11-05 | 2014-05-07 | 旭 酒井 | 透析装置 |
| US20140350097A1 (en) | 2013-05-23 | 2014-11-27 | Medinox,Inc. | Treatment of hypotension associated with hemodialysis |
| WO2016094409A1 (en) * | 2014-12-09 | 2016-06-16 | Villarreal Anna | Methods and devices for female health monitoring |
| ES2992792T3 (en) | 2017-03-08 | 2024-12-18 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| IL301302B2 (en) | 2017-03-08 | 2024-09-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium nitrite |
-
2018
- 2018-03-06 ES ES18764116T patent/ES2992792T3/es active Active
- 2018-03-06 IL IL302827A patent/IL302827B2/en unknown
- 2018-03-06 KR KR1020247030238A patent/KR102758644B1/ko active Active
- 2018-03-06 JP JP2019548683A patent/JP7416622B2/ja active Active
- 2018-03-06 NZ NZ756704A patent/NZ756704A/en unknown
- 2018-03-06 CA CA3055107A patent/CA3055107A1/en active Pending
- 2018-03-06 EP EP18764116.2A patent/EP3592824B1/en active Active
- 2018-03-06 IL IL312724A patent/IL312724A/en unknown
- 2018-03-06 KR KR1020247041494A patent/KR20250007674A/ko active Pending
- 2018-03-06 KR KR1020197029238A patent/KR102647836B1/ko active Active
- 2018-03-06 BR BR112019018646-8A patent/BR112019018646A2/pt active IP Right Grant
- 2018-03-06 WO PCT/US2018/021069 patent/WO2018165108A1/en not_active Ceased
- 2018-03-06 EP EP24181083.7A patent/EP4403215A3/en active Pending
- 2018-03-06 AU AU2018231072A patent/AU2018231072B2/en active Active
- 2018-03-06 IL IL268883A patent/IL268883B/en unknown
- 2018-03-06 KR KR1020247008181A patent/KR102706439B1/ko active Active
- 2018-03-06 IL IL295119A patent/IL295119B2/en unknown
- 2018-03-07 TW TW107107748A patent/TWI789378B/zh active
- 2018-03-07 TW TW111149188A patent/TWI869743B/zh active
- 2018-03-07 AR ARP180100530A patent/AR111236A1/es not_active Application Discontinuation
- 2018-03-07 US US15/914,661 patent/US10744156B2/en active Active
- 2018-03-07 TW TW113148262A patent/TW202517284A/zh unknown
-
2019
- 2019-08-28 PH PH12019501971A patent/PH12019501971A1/en unknown
-
2020
- 2020-07-13 US US16/927,901 patent/US11116790B2/en active Active
-
2021
- 2021-08-09 US US17/397,353 patent/US11779596B2/en active Active
- 2021-08-13 ZA ZA2021/05781A patent/ZA202105781B/en unknown
-
2022
- 2022-08-15 ZA ZA2022/09104A patent/ZA202209104B/en unknown
-
2023
- 2023-08-29 US US18/239,405 patent/US12370212B2/en active Active
-
2024
- 2024-01-04 JP JP2024000105A patent/JP7642878B2/ja active Active
- 2024-05-29 AU AU2024203603A patent/AU2024203603A1/en active Pending
-
2025
- 2025-02-26 JP JP2025028476A patent/JP2025084833A/ja active Pending
- 2025-07-02 US US19/258,074 patent/US20250332194A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202209104B (en) | Intradialytic use of sodium thiosulfate | |
| ZA202307367B (en) | Intradialytic use of sodium nitrite | |
| MX2021002321A (es) | Nuevos metodos. | |
| MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
| MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
| MX2015014408A (es) | Co-agonista de peptido similar a glucagon tipo 1 (glp-1) receptor de glucagon de larga duracion, estables para uso medico. | |
| PH12016502355A1 (en) | Pharmaceutical composition | |
| MX2022011334A (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert. | |
| EP4570314A3 (en) | Sacubitril-valsartan dosage regimen for treating chronic systolic heart failure | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX2017008486A (es) | Combinaciones del inhibidor de tirosina cinasa de bruton (btk) y regimenes de dosificacion. | |
| PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer | |
| WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12014500381A1 (en) | Therapeutic methods | |
| MY200278A (en) | Methods of improving exercise capacity in fontan patients using udenafil compositions | |
| MX2017015664A (es) | Administracion intravenosa de citrulina durante cirugia. | |
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
| PH12016501101A1 (en) | Veliparib in combination with carboplatin for the treatment of triple negative breast cancer | |
| SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
| EA201590760A1 (ru) | Применение бремеланотида в терапии женской сексуальной дисфункции | |
| MX2020006451A (es) | Tratamiento de la fibrosis con inositol. | |
| UA83680U (ru) | Способ комплексной реабилитации больных нейродермитом | |
| UA103987C2 (ru) | Способ терновской т.а. лечения варикозной болезни детей |